Clinical Implications of Gut-Lung Axis in Systemic Chemotherapy for Lung Cancer
Open Access
- 10 February 2026
- journal article
- Published by PT Kalbe Farma Tbk. in Cermin Dunia Kedokteran
- Vol. 53 (02) , 127-136
Abstract
Lung cancer incidence continues to increase globally, with an estimated mortality rate of 18% worldwide. Current management strategies focus on early screening, early treatment, and palliative care. However, more fundamental approaches are needed to improve treatment outcomes. The gut-lung axis has emerged as an important factor in lung cancer pathophysiology, as it plays a role in pulmonary immune defense and is influenced by changes in gut and lung microbiota. Alterations in microbial composition have been observed in lung cancer patients and may contribute to disease progression. Systemic chemotherapy, while targeting cancer cells, also exerts systemic effects that may disrupt gut and lung microbiota, leading to dysbiosis. These changes may influence treatment response, immune modulation, and clinical outcomes in lung cancer patients. This narrative review explores the role of the gut-lung axis in lung cancer and examines the impact of systemic chemotherapy on gut and lung microbiota. Understanding the interaction between chemotherapy and the gut-lung axis may provide insight into potential adjuvant strategies to improve treatment effectiveness and patient quality of life.Keywords
This publication has 50 references indexed in Scilit:
- Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient careBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- Role of lung and gut microbiota on lung cancer pathogenesisJournal of Cancer Research and Clinical Oncology, 2021
- The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLCJournal of Thoracic Oncology, 2019
- Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosaJournal of Cachexia, Sarcopenia and Muscle, 2019
- The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy‐induced gastrointestinal toxicityInternational Journal of Cancer, 2018
- Role of microbiota on lung homeostasis and diseasesScience China Life Sciences, 2017
- Gram-positive pneumonia augments non-small cell lung cancer metastasisviahost toll-like receptor 2 activationInternational Journal of Cancer, 2017
- Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory EffectsImmunity, 2016
- High-throughput 16S rRNA gene sequencing reveals alterations of mouse intestinal microbiota after radiotherapyAnaerobe, 2015
- The microbiome of the lungTranslational Research, 2012